Area of research
Epidemiology · Oncology
Research interest
Research interests include Neuroendocrine Tumor Research Advances, Lung Cancer Research Studies, Neuroblastoma Research and Treatments, and Pituitary Gland Disorders and Treatments.
BDNF and TNF-α, OCT and VF Parameters in Pituitary Macroadenoma Patients: A 12-Month Prospective Study.
Immunosuppressive Environment of Pancreatic NENs-A Review.
Treatment of hypoparathyroidism (HypoPT): Position Statement of the Expert Group for Polish Society of Endocrinology - update 2026.
Lipidogram profiles in patients with Graves' and Basedow's disease with and without orbitopathy.
Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task Force.
Controversies in NEN: An ENETS position statement on nutritional support in neuroendocrine neoplasms.
The Relationship Between the Ganglion Cell-Inner Plexiform Layer, Retinal Nerve Fiber Layer, and Photopic Negative Response in Newly Diagnosed Pituitary Macroadenoma: 12-Month Prospective Follow-Up Study.
EndoCompass project: research roadmap for pituitary and neuroendocrine tumor endocrinology
Antibodies against the receptor for insulin-like growth factor 1 (IGF-1RAb), insulin-like growth factor 1 (IGF-1), and insulin-like growth factor binding protein 3 (IGFBP-3) in the serum of patients with Graves' and Basedow's disease with and without orbitopathy.
EndoCompass Project: Research Roadmap for Pituitary and Neuroendocrine Tumor Endocrinology
The Clinical Utility of Selected Coagulation Parameters in Predicting the Risk of Venous Thromboembolism in Neuroendocrine Tumours: A Prospective, Single-Centre Study.
Efficacy and safety of radioligand therapy in a 76-year-old patient with metastatic grade 2 pancreatic neuroendocrine tumor.
The Polish radioligand therapy (RLT) Registry: initial real-world evidence in neuroendocrine tumors.
European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours.
Use and perceived utility of [<sup>18</sup> F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022.
Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force.
Interleukin (IL)-23, IL-31, and IL-33 Play a Role in the Course of Autoimmune Endocrine Diseases.
Transforming growth factors β and their signaling pathway in renal cell carcinoma and peritumoral space-transcriptome analysis.
Differential diagnosis of thyroid orbitopathy - diseases mimicking the presentation or activity of thyroid orbitopathy.
Acromegaly in Speckle Tracking Echocardiography-A New Cardiac Hypertrophy Phenotype? Case Report and Review.
Significant improvement of ganglion cell complex in optical coherence tomography and photopic negative response in electroretinography after transsphenoidal resection of pituitary macroadenoma.
The position of monoclonal antibodies and small molecules in the treatment of thyroid orbitopathy.
Adrenal tumours and subclinical adrenal hyperfunction.
Adverse Events of Radioligand Therapy in Patients with Progressive Neuroendocrine Neoplasms: The Biggest Eastern European Prospective Study.
Adipokines in Neuroendocrine Tumors: An Evaluation of the Serum Levels of Ghrelin and Leptin.
Evaluation of selected circulating cytokines from the IL-6 family - interleukin 6, oncostatin M, and cardiotrophin-1 - in gastro-entero-pancreatic and bronchial neuroendocrine tumours.
Angiogenic biomarkers of response to treatment with peptide receptor radionuclide therapy in neuroendocrine tumours.
Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland
Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland.
European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours.